Core Laboratories (CLB) Reports In-Line Q1 EPS, Offers FY and Q2 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Morgan Stanley Downgrades Core Laboratories (CLB) to Underweight
April 24, 2014 6:59 AM EDTMorgan Stanley downgraded Core Laboratories (NYSE: CLB) from Overweight to Underweight.
For an analyst ratings summary and ratings history on Core Laboratories click here. For more ratings news on Core Laboratories click here.
Shares of Core Laboratories closed at $213.69 yesterday.
... More